Table 2.
GeneHancer promoters and enhancers in the haplotype regions associated with the risk of MGUS, details extracted via GeneCards.
Haplotype chr: SNPa | GeneHancer (GH) Identifier | GH Type | GH Score | GH Sources | Gene Association Score | ENCODE transcription factor (TF) binding sites | Gene Targetsc | Cells and tissuesd | RoadMap Epigenomicse |
---|---|---|---|---|---|---|---|---|---|
chr1: rs11368313 | GH01J019798 | Promoter/Enhancer | 1.9b | RefSeq, EPDnew, Ensembl, ENCODE, CraniofacialAtlas | 260.60b | 110 TFs | 6 genes; TMCO4 | B-cells, immune cells, many other cells and tissues | B-cells, immune cells, many other cells |
GH01J019812 | Promoter/Enhancer | 1.7b | RefSeq, EPDnew, Ensembl, ENCODE, dbSUPER | 259.30b | 49 TFs | 7 genes; TMCO4, RNF186, OTUD3 | |||
chr4: rs10006825 | GH04J026131 | Enhancer | 1.1b | FANTOM5, Ensembl, ENCODE | 17.60b | 46 TFs | 6 genes; RBPJ | Immune cells | B-cells, T-cells, natural killer cells |
chr6: rs10658790 | GH06J125955 | Promoter/Enhancer | 2.6b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 250.70b | 313 TFs | 7 genes; HINT3, TRMT11 | B-cells, immune cells, many other cells and tissues | B-cells, other immune cells, many other cells |
chr10: rs10567579 | GH10J132962 | Promoter/Enhancer | 1.4 | RefSeq, Ensembl, ENCODE, CraniofacialAtlas | 250.70b | 20 TFs | 7 genes; LINC01168, LINC01166 | B-cells, immune cells, many other cells and tissues | B-cells, other immune cells, many other cells |
GH10J133008 | Enhancer | 1.3b | RefSeq, ENCODE, CraniofacialAtlas, dbSUPER | 29.7 | 43 TFs | 12 genes; LINC01168 | Some immune cells | Monocytes, neutrophils, natural killer cells | |
GH10J133012 | Enhancer | 1.3b | RefSeq, FANTOM5, ENCODE, dbSUPER | 28.1 | 15 TFs | 8 genes; LINC01168 | Monocytes | Monocytes, neutrophiles, natural killer cells | |
chr11: rs106282082 | GH11J134729 | Enhancer | 0.8b | RefSeq, ENCODE, dbSUPER | 256.80b | 4 TFs | 5 genes; LINC02714 | ||
chr17: rs111362005 | GH17J000914 | Enhancer | 1.5b | RefSeq, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 6.40b | 17 TFs | 7 genes; NXN | Neutrophils, some other cells and tissues | Neutrophils, some other cells |
GH17J000924 | Promoter/Enhancer | 1.8b | RefSeq, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 17.90b | 162 TFs | 12 genes; NXN | Some cells and tissues | Some cells | |
GH17J000931 | Promoter/Enhancer | 1.6b | Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 29.60b | 122 TFs | 12 genes; NXN | Some cells and tissues | ||
chr17: rs1024819 | GH17J057521 | Enhancer | 1.6b | RefSeq, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 0.06 | 114TFs | 9 genes; MSI2 | B-cells, immune cells; SE_13320 (CD34 primary cells); many other cells and tissues | B-cells, some other immune cells, some other cells |
chr17: rs10163481 | GH17J077084 | Enhancer | 0.4b | Ensembl, ENCODE, dbSUPER | 255.60b | no | 6 genes; SNHG20 | ||
GH17J077087 | Promoter/Enhancer | 2.5b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 250.70b | 263TFs | 10 genes; SEC14L1, SNHG20 | B-cells, immune cells | B-cells, other immune cells, many other cells | |
GH17J077095 | Enhancer | 1.3b | FANTOM5, Ensembl, ENCODE, dbSUPER | 26.60b | 83 TFs | 8 genes; SEC14L1, SNHG20 | Immune cells | Immune cells, many other cells | |
GH17J077106 | Promoter/Enhancer | 1.9b | RefSeq, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 18.50b | 121 TFs | 10 genes; SEC14L1 | B-cells, lymphocyte of B lineage, immune cells | B-cells, other immune cells, many other cells | |
GH17J077114 | Promoter/Enhancer | 2.0b | RefSeq, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 10.20b | 233 TFs | 9 genes; SEC14L1 | B-cells, immune cells | B-cells, immune cells, many other cells | |
GH17J077137 | Promoter/Enhancer | 2.6b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 259.8b | 300 TFs | 12 genes; SEC14L1 | B-cells, immune cells, other cells | B-cells, immune cells, many other cells | |
GH17J077150 | Enhancer | 0.3b | ENCODE, dbSUPER | 7.20b | no | 7 genes; SEC14L1 | |||
GH17J077152 | Enhancer | 0.3b | ENCODE, dbSUPER | 7.20b | no | 6 genes; SEC14L1 | |||
GH17J077159 | Promoter/Enhancer | 1.2b | RefSeq, ENCODE, dbSUPER | 7.20b | 54 TFs | 7 genes; SEC14L1 | B-cells | B-cells, immune cells, some other cells | |
chr19: rs10420324 | GH19J053864 | Promoter/Enhancer | 2.6b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 265.10b | 255 TFs | 39 genes; MYADM, ZNF765, ZNF813, ZNF761, CNOT3, PRKCG | B-cells, immune cells; SE_20401 (CD56 primary cells), SE in many immune cells | B-cells, immune cells, many other cells |
GH19J053874 | Enhancer | 0.6b | ENCODE, dbSUPER | 11.00b | 5 TFs | 6 genes; MYADM | B-cells, immune cells; SE_20401 (CD56 primary cells), SE in many immune cells | B-cells, immune cells | |
GH19J053877 | Enhancer | 0.6b | ENCODE, dbSUPER | 6.90b | 5 TFs | 10 genes; PRKCG | B-cells; SE in some immune cells | Many cells | |
GH19J053889 | Enhancer | 0.8b | ENCODE, dbSUPER | 18.50b | 24 TFs | 6 genes; MYADM | Immune cells | B-cells, monocytes, natural killer cells | |
GH19J053907 | Promoter/Enhancer | 1.2b | FANTOM5, Ensembl, ENCODE | 260.40b | 31 TFs | 8 genes; CACNG7, PRKCG, CACNG8 | |||
GH19J053956 | Promoter/Enhancer | 1.8b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE | 260.40b | 54 TFs | 23 genes; CACNG8, CACNG7 | |||
GH19J053977 | Promoter/Enhancer | 1.5b | RefSeq, Ensembl, ENCODE | 18.50b | 149 TFs | 27 genes; CACNG8 | B-cells, immune cells | Some cells | |
chr20: rs1051904 | GH20J004133 | Enhancer | 1.7b | efSeq, FANTOM5, Ensembl, ENCODE, dbSUPER | 3.00b | 149TFs | 10 genes; SMOX | Monocytes, neutrophils, other cells and tissues | Some cells |
GH20J004148 | Promoter/Enhancer | 2.0b | RefSeq, EPDnew, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 268.70b | 83 TFs | 6 genes; SMOX | Immune cells, many other cells | ||
GH20J004159 | Enhancer | 1.2b | RefSeq, FANTOM5, ENCODE, dbSUPER | 8.60b | 20 TFs | 6 genes; SMOX | Monocytes | B-cells, other immune cells, many other cells | |
GH20J004165 | Enhancer | 1.5b | RefSeq, FANTOM5, ENCODE, CraniofacialAtlas, dbSUPER | 20.7b | 36 TFs | 9 genes; SMOX | Some cells | ||
GH20J004169 | Promoter/Enhancer | 2.1b | RefSeq, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 7.90b | 190 TFs | 7 genes; SMOX | B-cells, immune cells | B-cells, other immune cells, many other cells | |
chr20: rs111797554 | GH20J057617 | Promoter/Enhancer | 2.0b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE, dbSUPER | 264.30b | 67 TFs | 4 genes; ZBP1 | B-cells, immune cells; SE_20522 (CD56 primary cells), SE_16712 (CD4 naive primary cells) | B-cells, immune cells, gastrointestinal tract |
GH20J057627 | Enhancer | 1.1b | FANTOM5, ENCODE, CraniofacialAtlas, dbSUPER | 11.90b | 13 TFs | 8 genes; ZBP1 | B-cells, immune cells; SE_20522 (CD56 primary cells), SE_16712 (CD4 naive primary cells) | B-cells, other immune cells, many other cells | |
chr 22: rs1045588 | GH22J017767 | Enhancer | 1.2b | RefSeq, ENCODE, dbSUPER | 4.90b | 49 TFs | 4 genes; BID | Immune cells; SE_09461 (CD14+ monocytes) | B-cells, other immune cells, some other cells |
GH22J017769 | Promoter/Enhancer | 2.5b | RefSeq, EPDnew, FANTOM5, Ensembl, ENCODE, CraniofacialAtlas, dbSUPER | 264.80b | 155 TFs | 7 genes; BID | B-cells, immune cells; SE_09461 (CD14+ monocytes); many cells and tissues | B-cells, other immune cells, many other cells | |
GH22J017784 | Enhancer | 1.8b | RefSeq, VISTA, ENCODE, CraniofacialAtlas, dbSUPER | 0.41 | 153 TFs | 8 genes | B-cells, immune cells; SE_09461 (CD14+ monocytes) | Immune cells, many other cells | |
GH22J017794 | Enhancer | 1.6b | RefSeq, FANTOM5, Ensembl, ENCODE, dbSUPER | 15.80b | 83 TFs | 10 genes; BID, MICAL3 | B-cells, immune cells; SE_09461 (CD14+ monocytes) | B-cells, monocytes, hematopoietic stem cells, natural killer cells |
aHaplotype identified by the chromosome and the joint SNP in the haplotype region.
bDouble Elite GeneHancer score and Gene association score.
cNumber of gene targets; Gene targets in the haplotype region.
dExamples of tissues, in which the promoter/enhancer is active in GeneHancer sources; Superenhancer (SE) in B-cells or immune cells.
eCell populations with active chromatin state in 6 immune cell populations and over 10 adult cell and tissue types were extracted via Roadmap Epigenomics.